Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03014362 · ClinicalTrials.gov registry record · NA
TMS for Suicidal Crisis in Active Duty SMs
A NA study of Suicide and Suicidal Ideation, sponsored by Eisenhower Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT03014362: Completed NA study of Suicide and Suicidal Ideation, sponsored by Eisenhower Army Medical Center.
NCT03014362 is a NA study of Suicide and Suicidal Ideation that has completed, run by Eisenhower Army Medical Center. The registered enrollment target is 120 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03014362, a NA study of Suicide and Suicidal Ideation, has completed, sponsored by Eisenhower Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the use of Transcranial Magnetic Stimulation (TMS) provides rapid reduction and sustained attenuation of suicidal crisis. TMS is a treatment for suicidal crisis that is quicker, less invasive, better tolerated, and with fewer side effects than current treatments such as Electroconvulsive Therapy (ECT) and medication therapies. There will be 6 months of follow-up, in order to establish the ongoing and lasting therapeutic effect of TMS.
Primary Outcome
The Beck Scale for Suicidal Ideation (SSI-T) is a 19-item clinician administered scale measuring current suicide ideation (SSI-C), suicide ideation at its worst point in the patient's life (SSI-W), and degree of hopelessness. The scale has been well validated. SSI-T scores range from 0-38, with higher scores indicating greater suicide risk.
Conditions Studied
Interventions
- DEVICE Neuronetics NeuroStar XPLOR magnetic stimulator - Active
- DEVICE Neuronetics NeuroStar XPLOR magnetic stimulator - Sham
Study Locations (1)
Georgia
- Eisenhower Army Medical Center - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2017-06-12 |
| Est. Completion | 2021-09-10 |
| Phase | NA |
What the finished NCT03014362 record still lists
NCT03014362 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (98% lower).
The record links to 6 conditions, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Neuronetics NeuroStar XPLOR magnetic stimulator - Active is the first listed.
NCT03014362 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT03014362 about?
NCT03014362 is a clinical study titled "TMS for Suicidal Crisis in Active Duty SMs". The purpose of this study is to determine if the use of Transcranial Magnetic Stimulation (TMS) provides rapid reduction and sustained attenuation of suicidal crisis. TMS is a treatment for suicidal crisis that is quicker, less invasive, better tolerated, and with fewer side effects than current tre...
What is the current status of trial NCT03014362?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2017-06-12. Estimated completion is 2021-09-10.
What conditions does trial NCT03014362 study?
This clinical trial studies the following conditions: Suicide, Suicidal Ideation, Suicidal Intention, Suicidal and Self-injurious Behavior, Suicidal Impulses.
What interventions are being tested in trial NCT03014362?
The interventions under investigation include: Neuronetics NeuroStar XPLOR magnetic stimulator - Active (DEVICE), Neuronetics NeuroStar XPLOR magnetic stimulator - Sham (DEVICE).
Who is sponsoring clinical trial NCT03014362?
This trial is sponsored by Eisenhower Army Medical Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03014362 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03014362's enrollment target sits among peer trials
120 44th of 92 higher than 49 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI